TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT07239310: A Prospective, Multicenter, Randomized, Double-Blind, Parallel-Group, Confirmatory Clinical Trial to Verify the Efficacy and Safety of the Cognitive Improvement Effect on Executive Function in Medication-Treated Patients

Sponsor: Deepsonbio · Phase: PHASE2 · Area: CNS_NEUROLOGY · Target Enrollment: 138 pts

Competing Trials Overlap

2 Active Trials

Excess Burn Exposure

$3,065,200

Rescue Site Savings

+$2,017,600

Unlock Full NCT07239310 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07239310 Rescue Dossier →